{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:38:05Z","timestamp":1792805885543,"version":"4.5.0"},"reference-count":52,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deanship of Graduate Studies and Scientific Research, Jouf University","award":["DGSSR-2024-01-02184"],"award-info":[{"award-number":["DGSSR-2024-01-02184"]}],"id":[{"id":"https:\/\/ror.org\/02zsyt821","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objective: Alcoholic liver disease (ALD) is a major health burden caused by chronic alcohol consumption, leading to oxidative stress, inflammation, and fibrosis. Current treatments are limited, highlighting the need for novel therapeutic agents. This study investigated the hepatoprotective effects of \u2018Terpinen-4-ol (T4OL)\u2019, a natural monoterpene from tea tree oil, against ethanol-induced liver injury, focusing on its molecular and cellular mechanisms. Materials and Methods: Network pharmacology and molecular docking were employed to predict T4OL\u2019s interaction with ALD-associated targets. Human HepG2 cells were used to validate the in silico findings. Cells were exposed to ethanol (8%) prior to treatment with T4OL or silymarin (SIL), and cytotoxicity was assessed through MTT, crystal violet, and trypan blue assays. Moreover, ELISA and qPCR were conducted to evaluate antioxidant, inflammatory, and fibrotic markers. Results: Network pharmacology analysis suggested that T4OL exerts its hepatoprotective effects by suppressing inflammatory and fibrotic mediators (HIF-1\u03b1, TGF-\u03b21, and TNF-\u03b1). Docking studies also exhibited a strong binding affinity of T4OL to key ALD targets, with docking scores comparable to SIL. In addition, T4OL (13\u20131300 \u00b5M) dose-dependently protected HepG2 cells from ethanol-induced damage, restoring viability by up to 80% at 650 \u00b5M. It significantly elevated antioxidant levels (GSH by 2.5-fold, SOD by 1.8-fold) and suppressed pro-inflammatory and fibrotic markers (IL-6, COL1A1, TIMP-1) by 40\u201360%. At higher concentrations (650\u20131300 \u00b5M), T4OL outperformed SIL in cytoprotection and anti-fibrotic effects. Conclusions: T4OL mitigates ethanol-induced liver injury by targeting oxidative stress, inflammation, and fibrosis pathways, demonstrating superior efficacy to SIL at optimal doses. Its multi-target action supports its potential as a therapeutic candidate for ALD.<\/jats:p>","DOI":"10.3390\/medicina61061048","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T06:11:08Z","timestamp":1749190268000},"page":"1048","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Terpinen-4-ol Targets HIF-1\u03b1\/TGF-\u03b21\/TNF-\u03b1 Axis to Attenuate Ethanol-Induced Hepatotoxicity: Network Pharmacology and In Vitro Validation"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3001-867X","authenticated-orcid":false,"given":"Tariq G.","family":"Alsahli","sequence":"first","affiliation":[{"name":"Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Khalid","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, The University of Lahore, Lahore 54000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2657-9810","authenticated-orcid":false,"given":"Muhammad Nasir Hayat","family":"Malik","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, The University of Lahore, Lahore 54000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6251-3149","authenticated-orcid":false,"given":"Saud O.","family":"Alshammari","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy and Alternative Medicine, College of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1164\/rccm.2108091","article-title":"Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment","volume":"166","author":"Sharma","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat. Rev. Dis. Primer"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Seitz, H.K., and Neuman, M.G. (2021). The history of alcoholic liver disease: From an unrecognized disease to one of the most frequent diseases in hepatology. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040858"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kong, L.Z., Chandimali, N., Han, Y.H., Lee, D.H., Kim, J.S., Kim, S.U., Kim, T.D., Jeong, D.K., Sun, H.N., and Lee, D.S. (2019). Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112712"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG Clinical Guideline: Alcoholic Liver Disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: Pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cct.2013.08.002","article-title":"The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): Study protocol for a randomised controlled trial","volume":"36","author":"Morley","year":"2013","journal-title":"Contemp. Clin. Trials"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chen, Y., Singh, S., Matsumoto, A., Manna, S.K., Abdelmegeed, M.A., Golla, S., Murphy, R.C., Dong, H., Song, B.J., and Gonzalez, F.J. (2016). Chronic Glutathione Depletion Confers Protection against Alcohol-induced Steatosis: Implication for Redox Activation of AMP-activated Protein Kinase Pathway. Sci. Rep., 6.","DOI":"10.1038\/srep29743"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.toxlet.2015.03.002","article-title":"Inhibition of miR122a by Lactobacillus rhamnosus GG culture supernatant increases intestinal occludin expression and protects mice from alcoholic liver disease","volume":"234","author":"Zhao","year":"2015","journal-title":"Toxicol. Lett."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jat.1310","article-title":"Beneficial drugs for liver diseases","volume":"28","author":"Muriel","year":"2008","journal-title":"J. Appl. Toxicol."},{"key":"ref_12","first-page":"147","article-title":"Alcoholic Liver Disease: Pathogenesis and Current Management","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1053\/j.gastro.2013.02.032","article-title":"Reviews in basic and clinical gastroenterology and hepatology","volume":"144","author":"Nault","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jep.2012.11.029","article-title":"An ethnobotanical study of medicinal plants and traditional therapies on Batan Island, the Philippines","volume":"145","author":"Abe","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: A review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"ref_16","first-page":"336","article-title":"A promising bioactive component terpinen-4-ol: A review","volume":"1","author":"Yadav","year":"2016","journal-title":"Int. J. Pharmacog."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.fct.2007.09.106","article-title":"Biological effects of essential oils\u2014A review","volume":"46","author":"Bakkali","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s000110050746","article-title":"The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro","volume":"50","author":"Brand","year":"2001","journal-title":"Inflamm. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.0022-202X.2004.22236.x","article-title":"Terpinen-4-ol, the main component of Melaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human melanoma cells","volume":"122","author":"Calcabrini","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: A web server for target prediction of bioactive small molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1093\/bioinformatics\/btt322","article-title":"DIGEP-Pred: Web service for in silico prediction of drug-induced gene expression profiles based on structural formula","volume":"29","author":"Lagunin","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/1062936X.2015.1078407","article-title":"PASS Targets: Ligand-based multi-target computational system based on a public data and naive Bayes approach","volume":"26","author":"Pogodin","year":"2015","journal-title":"SAR QSAR Env. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"W726","DOI":"10.1093\/nar\/gkac297","article-title":"SuperPred 3.0: Drug classification and target prediction-a machine learning approach","volume":"50","author":"Gallo","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: A web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"D1302","DOI":"10.1093\/nar\/gkaa1027","article-title":"Open Targets Platform: Supporting systematic drug-target identification and prioritisation","volume":"49","author":"Ochoa","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Jia, A., Xu, L., and Wang, Y. (2021). Venn diagrams in bioinformatics. Brief. Bioinform., 22.","DOI":"10.1093\/bib\/bbab108"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Tang, D., Chen, M., Huang, X., Zhang, G., Zeng, L., Zhang, G., Wu, S., and Wang, Y. (2023). SRplot: A free online platform for data visualization and graphing. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0294236"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/nar\/gkg034","article-title":"STRING: A database of predicted functional associations between proteins","volume":"31","author":"Mering","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"D322","DOI":"10.1093\/nar\/gkj021","article-title":"The gene ontology (GO) project in 2006","volume":"34","author":"Consortium","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"ref_31","first-page":"262","article-title":"An extension strategy of Discovery Studio 2.0 for non-bonded interaction energy automatic calculation at the residue level","volume":"32","author":"Gao","year":"2011","journal-title":"Dongwuxue Yanjiu"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0092-8674(00)81699-2","article-title":"The crystal structure of the IkappaBalpha\/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation","volume":"95","author":"Huxford","year":"1998","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"14671","DOI":"10.1038\/ncomms14671","article-title":"Structural basis of homo- and heterotrimerization of collagen I","volume":"8","author":"Sharma","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gky473","article-title":"CASTp 3.0: Computed atlas of surface topography of proteins","volume":"46","author":"Tian","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2174\/1389201020666190821144633","article-title":"In-Vitro Anti-Proliferative, Apoptotic and Antioxidative Activities of Medicinal Herb Kalonji (Nigella sativa)","volume":"20","author":"Maqbool","year":"2019","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lee, J.Y., Kim, H., Jeong, Y., and Kang, C.H. (2021). Lactic Acid Bacteria Exert a Hepatoprotective Effect against Ethanol-Induced Liver Injury in HepG2 Cells. Microorganisms, 9.","DOI":"10.3390\/microorganisms9091844"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12011-022-03191-w","article-title":"Evaluation of Serum Selenium and Copper Levels with Inflammatory Cytokines and Indices of Oxidative Stress in Type 2 Diabetes","volume":"201","author":"Pouresmaeil","year":"2023","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_39","first-page":"501","article-title":"A review on hepatoprotective activity of medicinal plants","volume":"2","author":"Kumar","year":"2011","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Gan, Y., Tong, J., Zhou, X., Long, X., Pan, Y., Liu, W., and Zhao, X. (2021). Hepatoprotective Effect of Lactobacillus plantarum HFY09 on Ethanol-Induced Liver Injury in Mice. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.684588"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1007\/s10620-018-5168-3","article-title":"A COL1A1 promoter-controlled expression of TGF-\u03b2 soluble receptor inhibits hepatic fibrosis without triggering autoimmune responses","volume":"63","author":"Zhang","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Hayashi, M., Nomoto, S., Hishida, M., Inokawa, Y., Kanda, M., Okamura, Y., Nishikawa, Y., Tanaka, C., Kobayashi, D., and Yamada, S. (2014). Identification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-108"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-\u03b2 as major players and therapeutic targets","volume":"10","author":"Gressner","year":"2006","journal-title":"J. Cell Mol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","article-title":"TGF-beta in progression of liver disease","volume":"347","author":"Dooley","year":"2012","journal-title":"Cell Tissue Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis\u2014A systematic review with special emphasis on anti-fibrotic strategies","volume":"46","author":"Hemmann","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1515\/chem-2019-0041","article-title":"Dynamic Changes in MMP1 and TIMP1 in the Antifibrotic Process of Dahuang Zhechong Pill in Rats with Liver Fibrosis","volume":"17","author":"Lin","year":"2019","journal-title":"Open Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.31658","article-title":"Myeloid-Cell-Specific IL-6 Signaling Promotes MicroRNA-223-Enriched Exosome Production to Attenuate NAFLD-Associated Fibrosis","volume":"74","author":"Hou","year":"2021","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Scarlata, G.G.M., Colaci, C., Scarcella, M., Dallio, M., Federico, A., Boccuto, L., and Abenavoli, L. (2024). The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease. Diseases, 12.","DOI":"10.20944\/preprints202403.0030.v1"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 pathway in the liver: From physiopathology to therapy","volume":"64","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s41016-021-00235-3","article-title":"The increasing expression of GPX7 related to the malignant clinical features leading to poor prognosis of glioma patients","volume":"7","author":"Yao","year":"2021","journal-title":"Chin. Neurosurg. J."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Xiao, Z., Yu, X., Zhang, S., and Liang, A. (2022). The Expression Levels and Significance of GSH, MDA, SOD, and 8-OHdG in Osteochondral Defects of Rabbit Knee Joints. Biomed. Res. Int., 2022.","DOI":"10.1155\/2022\/6916179"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/01.ATV.0000229665.78997.0b","article-title":"Hypoxia converts human macrophages into triglyceride-loaded foam cells","volume":"26","author":"Bostrom","year":"2006","journal-title":"Arter. Thromb. Vasc. Biol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1048\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:47:38Z","timestamp":1760032058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["medicina61061048"],"URL":"https:\/\/doi.org\/10.3390\/medicina61061048","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}